- AUD/USD stays sidelined around intraday high following China data release.
- China NBS Manufacturing PMI improves but Non-Manufacturing PMI eases in November.
- Market sentiment improves as Omicron fears ebb, policymakers stay cautiously optimistic.
- US data, testimonies from Fed’s Powell and Treasury Secretary Yellen will join coronavirus update to direct immediate moves.
AUD/USD struggles to cheer activity data from the key customer China during early Tuesday, taking rounds to 0.7150 by the press time. Even so, the risk barometer pair prints mild gains amid receding fears from the South African covid strain, dubbed as Omicron.
China’s headline NBS Manufacturing PMI jumped back to expansion territory with above 50.0 numbers for the first time in three months but Non-Manufacturing PMI eased below market consensus and prior readouts during November. Following the data release, China says, “Economic mood is improving as 3 PMIs show expansion.”
It’s worth noting that the recent recovery in the US Treasury yields and firmer Asia-Pacific stocks, together with the US S&P 500 Futures, also underpin the AUD/USD strength.
The reason could be linked to US President Joe Biden’s rejection of lockdown’s need and from Fed Chair Jerome Powell who accepts covid challenges for inflation and jobs report but backs inflation pressure. Further, US Treasury Secretary Janet Yellen also placates market pessimism while pushing Congress to overcome the US debt limit deadlock, as well as highlighting the strength of the US economy.
On the contrary, news that the US global military posture highlighted the need to work with allies and partners to beef up deterrence against potential Chinese aggression and North Korean threats, per Kyodo News, adds to the US dollar’s safe-haven demand and challenge AUD/USD buyers. Furthermore, the market’s anxiety ahead of the week’s key data, like Fed Chair Jerome Powell’s testimony and jobs report for November, also probe the Aussie pair’s upside moves.
Other than the catalysts stated above, US CB Consumer Confidence for November and covid updates will also be important for the AUD/USD traders. Recently, ABC News confirms the fifth case of the covid variant in New South Wales.
AUD/USD wobbles around the yearly support line, inside the immediate rising channel for the last two days. Adding to the bearish bias is the descending RSI line and retreat of the bullish MACD line, not to forget sustained trading below 50-HMA and a weekly resistance trend line. That said, selling pressure could escalate on the clear downside break of the immediate channel, supported around 0.7120.
Additional important levels
|Today last price||0.7143|
|Today Daily Change||0.0012|
|Today Daily Change %||0.17%|
|Today daily open||0.7131|
|Previous Daily High||0.716|
|Previous Daily Low||0.7114|
|Previous Weekly High||0.7273|
|Previous Weekly Low||0.7111|
|Previous Monthly High||0.7557|
|Previous Monthly Low||0.7191|
|Daily Fibonacci 38.2%||0.7131|
|Daily Fibonacci 61.8%||0.7142|
|Daily Pivot Point S1||0.711|
|Daily Pivot Point S2||0.7088|
|Daily Pivot Point S3||0.7063|
|Daily Pivot Point R1||0.7156|
|Daily Pivot Point R2||0.7181|
|Daily Pivot Point R3||0.7203|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.